A return to the black in 2H 2017 4Q in-line;Cotai timing still uncertain Buy on dip for strong results, bullish sales guidance and low valuation Softer than expected FY17 - volume misses similar to NDP Strong growth achieved; relatively immune to potential policy tightening FY17 results in line with expectations; Flattish retail revenue into 2018E Several catalysts to drive the share price Strong Q4 results; Capacity bottleneck a key concern; Maintain HOLD Better 2018, But Uncertainties Ahead In-line 2017 Results. Tissue paper remains a growth driver.